Advisors Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,941
| Closed | -$24.1K | – | 1440 |
|
|
2023
Q1 | $24.1K | Sell |
3,941
-201
| -5% | -$1.23K | ﹤0.01% | 1371 |
|
|
2022
Q4 | $26.5K | Sell |
4,142
-39,026
| -90% | -$249K | ﹤0.01% | 1412 |
|
|
2022
Q3 | $414K | Sell |
43,168
-4,271
| -9% | -$41K | 0.01% | 969 |
|
|
2022
Q2 | $524K | Sell |
47,439
-9,883
| -17% | -$109K | 0.01% | 928 |
|
|
2022
Q1 | $954K | Sell |
57,322
-35,845
| -38% | -$597K | 0.01% | 824 |
|
|
2021
Q4 | $1.78M | Sell |
93,167
-1,611
| -2% | -$30.8K | 0.03% | 646 |
|
|
2021
Q3 | $2.34M | Buy |
94,778
+1,387
| +1% | +$34.2K | 0.04% | 548 |
|
|
2021
Q2 | $2.43M | Buy |
93,391
+16,432
| +21% | +$428K | 0.04% | 538 |
|
|
2021
Q1 | $2.44M | Buy |
76,959
+35,396
| +85% | +$1.12M | 0.04% | 521 |
|
|
2020
Q4 | $1.93M | Buy |
41,563
+36,130
| +665% | +$1.68M | 0.03% | 566 |
|
|
2020
Q3 | $179K | Buy |
5,433
+2,517
| +86% | +$82.9K | ﹤0.01% | 1200 |
|
|
2020
Q2 | $80K | Buy |
+2,916
| New | +$80K | ﹤0.01% | 1341 |
|